z-logo
open-access-imgOpen Access
The Transcription Factor Rv1453 Regulates the Expression of qor and Confers Resistant to Clofazimine in Mycobacterium tuberculosis
Author(s) -
Yuanyuan Li,
Ling Fu,
Weiyan Zhang,
Xi Chen,
Yu Lu
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s324043
Subject(s) - clofazimine , mycobacterium tuberculosis , electrophoretic mobility shift assay , transcription (linguistics) , biology , microbiology and biotechnology , reverse transcriptase , transcription factor , chemistry , gene , tuberculosis , biochemistry , polymerase chain reaction , immunology , medicine , leprosy , linguistics , philosophy , pathology
Clofazimine plays an important role in the treatment of drug-resistant tuberculosis. However, the mechanism of clofazimine resistance remains unclear. In order to slow down the occurrence of clofazimine resistance, it is necessary to study its resistance mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here